InspireMD, Inc. (NSPR) Stock Forecast
Data as of Sep 20, 2026Healthcare · Current price $0.82 (+7.91%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
NSPR vs Sector & Market
| Metric | NSPR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +328.4% | +22243.3% | +21.5% |
| P/E Ratio | -1.72 | 3.76 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $13M | $14M | $15M | 2 |
| 2027-12-31 | $25M | $27M | $30M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.82 | $-0.73 | $-0.66 | 1 |
| 2027-12-31 | $-0.69 | $-0.61 | $-0.55 | 2 |
Frequently Asked Questions
What is the analyst consensus for NSPR?
The consensus among 1 analysts covering InspireMD, Inc. (NSPR) is Buy with an average price target of $4.00.
What is the highest price target for NSPR?
The highest analyst price target for NSPR is $5.00.
What is the lowest price target for NSPR?
The lowest analyst price target for NSPR is $3.00.
How many analysts cover NSPR?
1 analysts have issued ratings for InspireMD, Inc. in the past 12 months.
Is NSPR a buy or sell right now?
Based on 1 analyst ratings, NSPR has a consensus rating of Buy (2.00/5) with a +328.4% upside to the consensus target of $4.00.
What are the earnings estimates for NSPR?
Analysts estimate NSPR will report EPS of $-0.73 for the period ending 2026-12-31, with revenue estimated at $14M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.